Form 4 for PCVX Vaxcyte, Inc.
Accepted 2025-09-10 00:00:00 ET · period of report 2025-09-08 · accession 0001960048-25-000008 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-09-10 | 2025-09-08 | PCVX | Cowan Elvia | SVP, Fin | F - Tax | $32.41 | -482 | 26.2K | -2% | -$15.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-09-08 | F | D | 482 | $32.41 | 26,156 | D | — | — | (F1) Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of RSUs. |